Moderna developing combination COVID-19 booster, flu shot
‘한방에 코로나-독감 동시 예방’…모더나, 콤보백신 개발중Moderna is developing a single dose vaccine that fights both COVID-19 and the seasonal flu.The U.S. pharmaceutical company ma…
Cayman Offers Multidisciplinary Lipid-Based Drug Delivery Capabilities
Cayman Chemical, leader in the synthesis, purification, and characterization of lipids, has partnered with NanoImaging Services and T&T Scientific to provide a multi-pronged platform that synthesizes,…
Pfizer-BioNTech vaccine ‘safe’ for kids aged 5-11; generates ‘robust immunity’
The COVID-19 vaccine developed by Pfizer and BioNTech has been found safe for children between five to 11 years of age and generates a “robust” immune response, the companies said on Monday. They had…
Moderna Announces Significant Advances Across Industry-Leading mRNA Portfolio at 2021 R&D Day
CAMBRIDGE, Mass., September 09, 2021–Moderna announces significant advances across industry-leading mRNA portfolio at 2021 R&D Day.
Armed With Two Patents, Psycheceutical Plans To Transform Psychedelic Drug Delivery
The delivery systems allow psychedelic drugs to bypass the stomach, liver and blood-brain barrier—making tinkering with certain psychedelic effects possible.
AI + Lasers + Your Cells Is the New Formula for Personalized Medicine
Cellino Biotech is mixing three disciplines: machine learning, laser physics and cell biology to create affordable treatments from your own cells. Imagine a future where you are diagnosed with a degenerative disease, such as Parksinson’s or Alzheimer’s, and within days an effective treatment, made from your own cells, is ready to be administered. That’s the …
AI + Lasers + Your Cells Is the New Formula for Personalized Medicine Read More »
National Institutes of Health awards Children’s National Hospital $6.7M to build out additional lab space at the new Children’s National Research & Innovation Campus, preparing phase II
National Institutes of Health awards Children’s National Hospital $6.7M to build out additional lab space at the new Children’s National Research & Innovation Campus, preparing phase II 09/22/2021 | 04:06pm EDT (You can enter multiple email addresses separated by commas) Message : *Required fields Washington D.C., Sept. 22, 2021 (GLOBE NEWSWIRE) — Children’s National Hospital …
Early-Stage Drug Candidate Diminishes Deficits in Parkinson’s Disease
Early-Stage Drug Candidate Diminishes Deficits in Parkinson’s Disease Chemical compound reduces alpha-synuclein, cell stress. Stefan Pulst, MD, Dr Med, and Daniel Scoles, PhD, University of Utah Health. Charlie Ehlert Stefan Pulst, MD, Dr Med, Chair of Neurology, University of Utah Health Charlie Ehlert Previous Next Newswise — University of Utah Health scientists have identified a …
Early-Stage Drug Candidate Diminishes Deficits in Parkinson’s Disease Read More »
RD Fund Launches Opus Genetics with $19M Seed Funding to Advance Gene Therapy Treatments for Blinding Conditions
RD Fund Launches Opus Genetics with $19M Seed Funding to Advance Gene Therapy Treatments for Blinding Conditions 09/22/2021 | 07:32am EDT (You can enter multiple email addresses separated by commas) Message : *Required fields Initial programs will focus on treatments for rare pediatric blinding conditions Company formed to advance the work of scientific cofounders Dr. …
The FDA Authorized a Booster Shot of the Pfizer-BioNTech COVID-19 Vaccine—But Not For Everyone
The FDA Authorized a Booster Shot of the Pfizer-BioNTech COVID-19 Vaccine—But Not For Everyone The FDA Authorized a Booster Shot of the Pfizer-BioNTech COVID-19 Vaccine—But Not For Everyone Lauren DeCicca—Getty Images By Alice Park September 22, 2021 9:02 PM EDT The U.S. Food and Drug Administration (FDA) on Sept. 22 authorized booster doses for certain …